Latest Breaking News On - Lucie larguier - Page 6 : comparemela.com

BioInvent and Transgene: First patient treated in Part B of Phase 1 trial assessing the novel oncolytic virus BT-001 in combination with KEYTRUDA® (pembrolizumab)

BioInvent and Transgene: First patient treated in Part B of Phase 1 trial assessing the novel oncolytic virus BT-001 in combination with KEYTRUDA® (pembrolizumab)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLucie larguierTransgene euronextSylvie berrebiCecilia hofvanderMartin welschofAlessandro rivaCorporate communicationsBioinvent international ab nasdaq stockholmBioinvent internationalMerck sharp dohmeMerck co incNasdaq stockholmEuronext parisMerck sharpArtificial intelligence

Transgene Advances Its Innovative Immunotherapy Pipeline and Extends Financial Visibility Until the End of 2024

Transgene Advances Its Innovative Immunotherapy Pipeline and Extends Financial Visibility Until the End of 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPedro romeroLucie larguierJohnc bellAlessandro rivaBen brahimChristian ottensmeierCarol stuckleyTransgene euronextCompany board of directorsUniversity of liverpoolCorporate communicationsUniversity of lausanneMerck coJolla institute for immunology

Availability of Transgene s Half-Year Financial Report as of June 30, 2023

Availability of Transgene s Half-Year Financial Report as of June 30, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalLucie larguierCorporate communications

Transgene Advances Its Innovative Immunotherapy Pipeline and Extends Financial Visibility Until the

Promising data from ongoing clinical trials of neoantigen cancer vaccine TG4050 and HPV-positive cancer therapeutic vaccine TG4001 presented at key congresses in H1 2023 Immunogenicity clinical data from ongoing trials confirm mechanism of action of Transgene’s therapeutic vaccines TG4050 and TG4001 Transgene pl.

United kingdomUnited statesLucie larguierChristian ottensmeierBen brahimJohnc bellCarol stuckleyTransgene euronextAlessandro rivaPedro romeroCorporate communicationsJolla institute for immunologyUniversity of lausanneMerck coCompany board of directorsUniversity of liverpool

Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited statesNew yorkBaden wübergTransgene euronextLucie larguierFrazer sylvie berrebiCorporate communicationsInvestor access forumRegulatory newsGlobal healthcare conferenceAccess forumTech innovation daysArtificial intelligenceRisk factorsUniversal registration document